European Journal of Clinical Pharmacology

Aims & Scope

The European Journal of Clinical Pharmacology publishes original papers on all aspects of clinical pharmacology and drug therapy in humans.

Manuscripts are welcomed on the following topics: therapeutic trials, pharmacokinetics/pharmacodynamics, pharmacogenetics, drug metabolism, adverse drug reactions, drug interactions, all aspects of drug development, development relating to teaching in clinical pharmacology, pharmacoepidemiology, and matters relating to the rational prescribing and safe use of drugs.

Methodological contributions relevant to these topics are also welcomed.

Data from animal experiments are accepted only in the context of original data in man reported in the same paper.

EJCP will only consider manuscripts describing the frequency of allelic variants in different populations if this information is linked to functional data or new interesting variants.

Highly relevant differences in frequency with a major impact in drug therapy for the respective population may be submitted as a letter to the editor.

Straightforward phase I pharmacokinetic or pharmacodynamic studies as parts of new drug development will only be considered for publication if the paper involves -a compound that is interesting and new in some basic or fundamental way, or -methods that are original in some basic sense, or -a highly unexpected outcome, or -conclusions that are scientifically novel in some basic or fundamental sense.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.7
2024	2.40

Journal Rank

Year	Value
2024	6225

Journal Citation Indicator

Year	Value
2024	1520

SJR (SCImago Journal Rank)

Year	Value
2024	0.849

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	126

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• A Bayesian neural network method for adverse drug reaction signal generation

  Citation: 1048

  Authors: A., M., I. R., S., R., A., R. M.

• Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction

  Citation: 548

  Authors: Roger K.

• Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology

  Citation: 515

  Authors: E. J.

• Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939—an oral, direct Factor Xa inhibitor—after multiple dosing in healthy male subjects

  Citation: 511

  Authors: Dagmar, Michael, Georg, Barbara, Michael

• The clinical pharmacology of 6-mercaptopurine

  Citation: 508

  Authors: L.

• Defective N-oxidation of sparteine in man: A new pharmacogenetic defect

  Citation: 474

  Authors: M., N., Barbara, H. J.

• Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers

  Citation: 417

  Authors: I., T., G., J., K., J., J., A.

• Potentially inappropriate medications in the elderly: a French consensus panel list

  Citation: 400

  Authors: Marie-Laure, Jean-Pierre, Louis

• Comparison of fixed interval and visual analogue scales for rating chronic pain

  Citation: 371

  Authors: C. R. B., D. W., V., R. M.

• The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries

  Citation: 359

  Authors: Anna, Gabriele, Petra A.

---